Hepatitis C virus--cell interactions and their role in pathogenesis.
暂无分享,去创建一个
[1] H. Thomas,et al. Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. , 1999, Gastroenterology.
[2] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[3] M. Katze,et al. Antiapoptotic and Oncogenic Potentials of Hepatitis C Virus Are Linked to Interferon Resistance by Viral Repression of the PKR Protein Kinase , 1999, Journal of Virology.
[4] D. Pessayre,et al. Hepatitis C virus core protein inhibits microsomal triglyceride transfer protein activity and very low density lipoprotein secretion: a model of viral‐related steatosis , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] David E. Misek,et al. An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. , 2002, Virology.
[6] K. Tsuchihara,et al. Hepatitis C virus core protein enhances the activation of the transcription factor, Elk1, in response to mitogenic stimuli , 2001, Hepatology.
[7] M. Lai,et al. Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor , 1997, Journal of virology.
[8] C. Tiribelli,et al. Epidemiology of hepatitis C virus infection in Italy: the slowly unraveling mystery. , 2000, Microbes and infection.
[9] S. Polyak,et al. Characterization of the effects of hepatitis C virus nonstructural 5A protein expression in human cell lines and on interferon‐sensitive virus replication , 1999, Hepatology.
[10] K. Lindsay. Therapy of hepatitis C: Overview , 1997, Hepatology.
[11] M. Houghton,et al. Expression, identification and subcellular localization of the proteins encoded by the hepatitis C viral genome. , 1993, The Journal of general virology.
[12] G. Pasero,et al. Infection of Peripheral Blood Mononuclear Cells by Hepatitis C Virus in Mixed Cryoglobulinemia , 1993 .
[13] M. Honda,et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. , 2002, Gastroenterology.
[14] Y. Matsuura,et al. Suppression of interferon-induced antiviral activity in cells expressing hepatitis C virus proteins. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[15] M. Levrero,et al. Sustained activation of the Raf/MEK/Erk pathway in response to EGF in stable cell lines expressing the Hepatitis C Virus (HCV) core protein , 2001, Oncogene.
[16] R. Thomssen,et al. Association of hepatitis C virus in human sera with β-lipoprotein , 2004, Medical Microbiology and Immunology.
[17] C. Rice,et al. The NS5A/NS5 Proteins of Viruses from Three Genera of the Family Flaviviridae Are Phosphorylated by Associated Serine/Threonine Kinases , 1998, Journal of Virology.
[18] M. Gerotto,et al. The molecular basis for responsiveness to anti-viral therapy in hepatitis C. , 2000, Forum.
[19] K. Meyer,et al. Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death , 2000 .
[20] M. Katze,et al. NS5A, a nonstructural protein of hepatitis C virus, binds growth factor receptor-bound protein 2 adaptor protein in a Src homology 3 domain/ligand-dependent manner and perturbs mitogenic signaling. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] G. Migliaccio,et al. Biosynthesis and biochemical properties of the hepatitis C virus core protein , 1994, Journal of virology.
[22] R. Eisenberg,et al. Three classes of cell surface receptors for alphaherpesvirus entry. , 2000, Virology.
[23] L. Beretta,et al. Activation of the interferon-inducible protein kinase PKR by Hepatocellular carcinoma derived-Hepatitis C virus core protein , 2001, Oncogene.
[24] M. Houghton,et al. Binding of hepatitis C virus to CD81. , 1998, Science.
[25] D. R. Taylor,et al. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein. , 1999, Science.
[26] S. Levy,et al. Primary hepatocytes of Tupaia belangeri as a potential model for hepatitis C virus infection. , 2002, The Journal of clinical investigation.
[27] R. Aebersold,et al. Ser(2194) is a highly conserved major phosphorylation site of the hepatitis C virus nonstructural protein NS5A. , 2000, Virology.
[28] N. Mukaida. Interleukin-8: an expanding universe beyond neutrophil chemotaxis and activation. , 2000, International journal of hematology.
[29] A. Siddiqui,et al. Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-κB , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[30] R. Silverman. 2-5A-Dependent RNase L: A Regulated Endoribonuclease in the Interferon System , 1997 .
[31] J. M. Calvo Romero,et al. Gastric adenocarcinoma and kidney transplantation , 1998 .
[32] S. Polyak,et al. Characterization of Pichinde virus infection of cells of the monocytic lineage , 1991, Journal of virology.
[33] M. Lai,et al. An internal polypyrimidine-tract-binding protein-binding site in the hepatitis C virus RNA attenuates translation, which is relieved by the 3'-untranslated sequence. , 1999, Virology.
[34] G. Davis,et al. Intrahepatic hepatitis C virus–specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C , 1998, Hepatology.
[35] B. Williams,et al. Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.
[36] S. Fields,et al. Hepatitis C Virus 3′X Region Interacts with Human Ribosomal Proteins , 2001, Journal of Virology.
[37] O. Jaillon,et al. Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity. , 1998, The Journal of general virology.
[38] S. Yap,et al. Hepatitis C virus‐RNAs in plasma and in peripheral blood mononuclear cells of hemophiliacs with chronic hepatitis C: Evidence for viral replication in peripheral blood mononuclear cells , 1994, Journal of medical virology.
[39] P. Bouffard,et al. Hepatitis C virus is detected in a monocyte/macrophage subpopulation of peripheral blood mononuclear cells of infected patients. , 1992, The Journal of infectious diseases.
[40] T. Asselah,et al. Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C. , 2001, Clinical biochemistry.
[41] R. De Francesco,et al. Hyperphosphorylation of the Hepatitis C Virus NS5A Protein Requires an Active NS3 Protease, NS4A, NS4B, and NS5A Encoded on the Same Polyprotein , 1999, Journal of Virology.
[42] C. Rice,et al. The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. , 2001, Virology.
[43] R. Purcell,et al. The hepatitis C virus: Overview , 1997, Hepatology.
[44] R. Silverman,et al. Stress responses: Translational control perks up , 1999, Nature.
[45] C. Rice,et al. Efficient initiation of HCV RNA replication in cell culture. , 2000, Science.
[46] Volker Brass,et al. An Amino-terminal Amphipathic α-Helix Mediates Membrane Association of the Hepatitis C Virus Nonstructural Protein 5A* , 2002, The Journal of Biological Chemistry.
[47] S. Ray,et al. Prospective Characterization of Full-Length Hepatitis C Virus NS5A Quasispecies during Induction and Combination Antiviral Therapy , 2000, Journal of Virology.
[48] B. Williams,et al. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. , 1999, Virology.
[49] P. Borrow,et al. Mechanism of lymphocytic choriomeningitis virus entry into cells. , 1994, Virology.
[50] R. Bartenschlager,et al. Mutations in Hepatitis C Virus RNAs Conferring Cell Culture Adaptation , 2001, Journal of Virology.
[51] J. Rakela,et al. The presence of active hepatitis C virus replication in lymphoid tissue in patients coinfected with human immunodeficiency virus type 1. , 1998, The Journal of infectious diseases.
[52] O. Hino,et al. Hepatitis C virus core protein activates the MAPK/ERK cascade synergistically with tumor promoter TPA, but not with epidermal growth factor or transforming growth factor α , 2000 .
[53] M. Alter,et al. Epidemiology of Hepatitis C: Geographic Differences and Temporal Trends , 2000, Seminars in liver disease.
[54] K. Shimotohno,et al. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A , 1995, Journal of virology.
[55] J. Dubuisson,et al. Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines , 2002, Journal of Virology.
[56] V. Carreño,et al. Detection of hepatitis C virus RNA in serum and peripheral blood mononuclear cells. , 1993, Journal of hepatology.
[57] Hua-Lin Wu,et al. Detection of hepatitis C virus RNA in peripheral blood mononuclear cells and in saliva , 1993, Journal of medical virology.
[58] C. Rice,et al. Identification of the Major Phosphorylation Site of the Hepatitis C Virus H Strain NS5A Protein as Serine 2321* , 1999, The Journal of Biological Chemistry.
[59] S. Schwartz,et al. The La protein from human liver cells interacts specifically with the U-rich region in the hepatitis C virus 3' untranslated region. , 1999, Journal of human virology.
[60] N. Kato,et al. Activation of the Interferon-Inducible 2′-5′-Oligoadenylate Synthetase Gene by Hepatitis C Virus Core Protein , 2000, Journal of Virology.
[61] Michael G. Katze,et al. Regulation of mRNA Translation and Cellular Signaling by Hepatitis C Virus Nonstructural Protein NS5A , 2001, Journal of Virology.
[62] A. Meola,et al. Binding of Hepatitis C Virus E2 Glycoprotein to CD81 Does Not Correlate with Species Permissiveness to Infection , 2000, Journal of Virology.
[63] K. Shimotohno,et al. The N-terminal region of hepatitis C virus-encoded NS5A is important for NS4A-dependent phosphorylation , 1997, Journal of virology.
[64] H. Blum,et al. Expression of Hepatitis C Virus Proteins Inhibits Signal Transduction through the Jak-STAT Pathway , 1999, Journal of Virology.
[65] C. Rice,et al. Continuous human cell lines inducibly expressing hepatitis C virus structural and nonstructural proteins , 1998, Hepatology.
[66] E. Schiff,et al. A randomized, double‐blind trial comparing pegylated interferon alfa‐2b to interferon alfa‐2b as initial treatment for chronic hepatitis C , 2001, Hepatology.
[67] Samir K. Gupta,et al. A Dose‐Ranging Study of Pegylated Interferon Alfa‐2b and Ribavirin in Chronic Hepatitis C , 2000 .
[68] T. Nowak,et al. Description of a procedure which allows isolation of viral nonstructural proteins from BHK vertebrate cells infected with the West Nile flavivirus in a state which allows their direct chemical characterization. , 1990, Virology.
[69] O. Haller,et al. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein , 1990, Journal of virology.
[70] P. J. Wright,et al. The sensitivity of cell-associated dengue virus proteins to trypsin and the detection of trypsin-resistant fragments of the nonstructural glycoprotein NS1. , 1991, Virology.
[71] K. Shimotohno,et al. Production of two phosphoproteins from the NS5A region of the hepatitis C viral genome. , 1994, Biochemical and biophysical research communications.
[72] Kyu-Jin Park,et al. Nonstructural 5A Protein of Hepatitis C Virus Modulates Tumor Necrosis Factor α-stimulated Nuclear Factor κB Activation* , 2002, The Journal of Biological Chemistry.
[73] K. Tsuchihara,et al. Hepatitis C virus core protein regulates cell growth and signal transduction pathway transmitting growth stimuli. , 1999, Virology.
[74] A. Helenius,et al. Inhibition of Semliki forest virus penetration by lysosomotropic weak bases. , 1982, The Journal of general virology.
[75] K Koike,et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. , 1997, The Journal of general virology.
[76] D. S. Chen,et al. Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. , 1992, The Journal of infectious diseases.
[77] B. Aggarwal,et al. Inhibition of Tumor Necrosis Factor (TNF-α)-mediated Apoptosis by Hepatitis C Virus Core Protein* , 1998, The Journal of Biological Chemistry.
[78] G. Duverlie,et al. Expression of Hepatitis C Virus Proteins Interferes with the Antiviral Action of Interferon Independently of PKR-Mediated Control of Protein Synthesis , 2000, Journal of Virology.
[79] V. Agnello,et al. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[80] M. Lai,et al. Hepatitis C virus core protein: possible roles in viral pathogenesis. , 2000, Current topics in microbiology and immunology.
[81] P. Marcellin,et al. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. , 1999, Journal of hepatology.
[82] Y. Sasaguri,et al. Hepatitis C virus NS5A protein is phosphorylated in vitro by a stably bound protein kinase from HeLa cells and by cAMP-dependent protein kinase A-α catalytic subunit , 1997 .
[83] M. Katze,et al. Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. , 1997, Virology.
[84] M. Lai. Hepatitis C virus proteins: direct link to hepatic oxidative stress, steatosis, carcinogenesis and more. , 2002, Gastroenterology.
[85] C. Tseng,et al. Binding of the Hepatitis C Virus Envelope Protein E2 to CD81 Inhibits Natural Killer Cell Functions , 2002, The Journal of experimental medicine.
[86] R. Bartenschlager,et al. Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations , 2001, Journal of Virology.
[87] Yoshiharu Matsuura,et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice , 1998, Nature Medicine.
[88] Michael G. Katze,et al. Control of PKR Protein Kinase by Hepatitis C Virus Nonstructural 5A Protein: Molecular Mechanisms of Kinase Regulation , 1998, Molecular and Cellular Biology.
[89] Philip Beineke,et al. Statistical analysis of combined substitutions in nonstructural 5A region of hepatitis C virus and interferon response , 2001, Journal of medical virology.
[90] N. Bishop. Examination of Potential Inhibitors of Hepatitis A Virus Uncoating , 1999, Intervirology.
[91] J. Choe,et al. Hepatitis C virus NS5A protein is phosphorylated by casein kinase II. , 1999, Biochemical and biophysical research communications.
[92] S. Kaneko,et al. Hepatitis C Virus (HCV) NS5A Binds RNA-dependent RNA Polymerase (RdRP) NS5B and Modulates RNA-dependent RNA Polymerase Activity* , 2002, The Journal of Biological Chemistry.
[93] N Enomoto,et al. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. , 1996, The New England journal of medicine.
[94] M. Lai,et al. Determination of the secondary structure of and cellular protein binding to the 3'-untranslated region of the hepatitis C virus RNA genome , 1997, Journal of virology.
[95] K. Matsushima,et al. Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. , 1997, Biochemical and biophysical research communications.
[96] K. Khabar,et al. Elevated Levels of Interleukin-8 in Serum Are Associated with Hepatitis C Virus Infection and Resistance to Interferon Therapy , 2001, Journal of Virology.
[97] N. Enomoto,et al. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. , 1995, The Journal of clinical investigation.
[98] D. Stump,et al. Evidence for a new hepatitis C virus antigen encoded in an overlapping reading frame. , 2001, RNA.
[99] N. Kato,et al. Phosphorylation of nonstructural 5A protein of hepatitis C virus: HCV group-specific hyperphosphorylation. , 1999, Virology.
[100] P. Marcellin,et al. Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. , 1998, Clinical biochemistry.
[101] K. Shimotohno,et al. Hepatitis C Virus Core Protein Inhibits Fas- and Tumor Necrosis Factor Alpha-Mediated Apoptosis via NF-κB Activation , 1999, Journal of Virology.
[102] B. Rollins,et al. Chemokines and disease , 2001, Nature Immunology.
[103] P. Marcellin,et al. Randomised trial of interferon α2b plus ribavirin for 48 weeks or for 24 weeks versus interferon α2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus , 1998, The Lancet.
[104] P. Spear,et al. Herpesviruses and heparan sulfate: an intimate relationship in aid of viral entry. , 2001, The Journal of clinical investigation.
[105] D. Fabbro,et al. The protein kinase C inhibitor CGP41251 suppresses cytokine release and extracellular signal-regulated kinase 2 expression in cancer patients. , 1999, Cancer research.
[106] C. Sawyers,et al. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. , 2001, The New England journal of medicine.
[107] T. Liang,et al. Emergence of a distinct pattern of viral mutations in chimpanzees infected with a homogeneous inoculum of hepatitis C virus. , 2001, Gastroenterology.
[108] G. Barber,et al. Hepatitis C Virus Nonstructural 5A Protein Induces Interleukin-8, Leading to Partial Inhibition of the Interferon-Induced Antiviral Response , 2001, Journal of Virology.
[109] A. Hughes,et al. The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes. , 2001, Immunity.
[110] S. Nuti,et al. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co‐stimulatory signal for human T cells , 2001, European journal of immunology.
[111] J. Prieto,et al. Replication of hepatitis C virus in peripheral blood mononuclear cells. Effect of alpha-interferon therapy. , 1992, Journal of hepatology.
[112] V. Stollar,et al. Low pH-induced cell fusion in flavivirus-infected Aedes albopictus cell cultures. , 1990, The Journal of general virology.
[113] K. Meyer,et al. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells. , 2000, Virology.
[114] W. Hong,et al. The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage. , 2001, Virology.
[115] M. Lai,et al. Hepatitis C Virus Core Protein Binds to the Cytoplasmic Domain of Tumor Necrosis Factor (TNF) Receptor 1 and Enhances TNF-Induced Apoptosis , 1998, Journal of Virology.
[116] S. Emerson,et al. Hepatitis C virus envelope protein E2 binds to CD81 of tamarins. , 2000, Virology.
[117] M. Massari,et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. , 1996, The Journal of clinical investigation.
[118] S. Nuti,et al. Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein , 2002, The Journal of experimental medicine.
[119] B. Ahn,et al. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. , 2002, Virology.
[120] K. Meyer,et al. Suppression of apoptotic cell death by hepatitis C virus core protein. , 1996, Virology.
[121] H. Handa,et al. Cleavage of hepatitis C virus nonstructural protein 5A by a caspase-like protease(s) in mammalian cells. , 2000, Virology.
[122] William M. Lee,et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[123] M. Lai,et al. Hepatitis C virus NS5A colocalizes with the core protein on lipid droplets and interacts with apolipoproteins. , 2002, Virology.
[124] J. Dubuisson. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. , 2000, Current topics in microbiology and immunology.
[125] D. R. Taylor,et al. Hepatitis C virus RNA polymerase and NS5A complex with a SNARE-like protein. , 1999, Virology.
[126] J. Hoefs,et al. Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group. , 1998, The New England journal of medicine.
[127] Ralf Bartenschlager,et al. Modulation of Hepatitis C Virus NS5A Hyperphosphorylation by Nonstructural Proteins NS3, NS4A, and NS4B , 1999, Journal of Virology.
[128] O. Laeyendecker,et al. Acute Hepatitis C Virus Structural Gene Sequences as Predictors of Persistent Viremia: Hypervariable Region 1 as a Decoy , 1999, Journal of Virology.
[129] Y. Matsuura,et al. Molecular basis of subcellular localization of HCV core protein. , 2008, Liver.
[130] R. Silverman,et al. Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.
[131] William M. Lee,et al. Efficacy and safety of pegylated (40‐kd) interferon α‐2a compared with interferon α‐2a in noncirrhotic patients with chronic hepatitis C , 2001 .
[132] M. Katze,et al. Constitutive expression of human double-stranded RNA-activated p68 kinase in murine cells mediates phosphorylation of eukaryotic initiation factor 2 and partial resistance to encephalomyocarditis virus growth , 1992, Journal of Virology.
[133] Y. Sasaguri,et al. Characterization of the nuclear localization signal and subcellular distribution of hepatitis C virus nonstructural protein NS5A. , 1996, Gene.
[134] A. Thiele,et al. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins , 1993, Medical Microbiology and Immunology.
[135] Frank Scholle,et al. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. , 2002, Gastroenterology.
[136] A. Bisceglie. Liver transplantation for hepatitis C: The promise and the challenge , 1995 .
[137] P Parham,et al. Analysis of a successful immune response against hepatitis C virus. , 1999, Immunity.
[138] A. Gabrielli,et al. Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia , 1994, Clinical and experimental immunology.
[139] Lars Holmgren,et al. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.
[140] Y. Sasaguri,et al. Modulation of Cell Growth by the Hepatitis C Virus Nonstructural Protein NS5A* , 2001, The Journal of Biological Chemistry.
[141] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[142] F. Sicheri,et al. Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A. , 2001, Virology.
[143] S. Kaneko,et al. Hepatitis C Virus NS5A Binds RNA-Dependent RNA polymerase NS5B and modulates RdRP activity , 2003 .
[144] I. Kerr,et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon , 1990, Cell.
[145] H. Hotta,et al. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. , 1999, The Journal of general virology.
[146] M. Kohara,et al. Hepatitis C virus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[147] C. Rice,et al. Phosphorylation of the hepatitis C virus NS5A protein in vitro and in vivo: properties of the NS5A-associated kinase , 1997, Journal of virology.
[148] M. Loriot,et al. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice , 1998, Hepatology.
[149] L. Ferrell,et al. Hepatitis C viral infection in liver transplant recipients , 1992, Hepatology.
[150] Y. Shirota,et al. Mutational analysis of the structure and functions of hepatitis C virus RNA–dependent RNA polymerase , 2001, Hepatology.
[151] J. Darnell,et al. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. , 1994, Science.